Why new battery technology will lead to disruptive medtech innovations

What’s the next big disruption in battery technology? Three experts from Integer, a global leader in medical device outsourcing, weigh in. Martin Cholette, Robert Rubino and Chris Williams, Integer What new technologies in medtech are being enabled by advances in battery technology? Chris Williams: One new technology is the leadless cardiac pacing market. Integer has developed

Integer to deal surgical, orthopedics assets to MedPlast for $600m

Integer Holdings (NYSE:ITGR) plans to sell its advanced surgical and orthopedic assets to MedPlast for $600 million in a deal that will double MedPlast’s top line and bolster the balance sheet for Integer, which missed expectations with its first-quarter earnings. Proceeds from the all-cash deal, announced yesterday and expected to close during the third quarter, are

Integer shares jump on strong Q4 earnings beat

Integer Holdings (NYSE:ITGR) yesterday handily topped the consensus earnings expectation and met sales forecasts with its fourth-quarter and full-year results. The Frisco, Texas-based medical device contract manufacturer posted profits of $54.3 million, or $1.68 per share, on sales of $390.5 million for the three months ended Dec. 29, 2018, for a bottom-line gain of 585.0% on

Cardiovascular Systems inks partnerships with OrbusNeich, Integer

Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The deal with Frisco, Texas–based Integer (NYSE: ITGR) involves Integer producing CSI-branded Zilient guidewires. Cardiovascular Systems CEO

Medical device companies: These 15 performed the best in 2017

Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Integer posts street-beating Q3

Integer today posted third quarter earnings that beat expectations on Wall Street. The Frisco, Texas-based company posted profits of $13.7 million, of 43¢ per share, on sales of $363.3 million for the 3 months ended September 29, seeing bottom-line growth of 19.5% while sales grew 4.8% compared to the same period last year. Adjusted to

How Integer is creating cutting-edge disposable ortho surgical tools

With health providers increasingly demanding single-use devices, Integer successfully created disposable bone-cutting tools for its orthopedic device customers. Gary Victor, Integer Within healthcare today, there is a heightened focus on “value” – on the episode of care and the need to deliver improved patient care outcomes and lower overall costs. A related trend in the

Integer Holdings: What you need to know

Greatbatch and Lake Region Medical merged nearly two years ago to become Integer Holdings Co., a giant medical device contract manufacturer that could theoretically do almost anything for an OEM. But can this colossus of a company execute on its expanded capabilities? When Greatbatch and Lake Region Medical merged in 2015, company officials decided they

Pages: 1 2 3

Integer misses expectations on Q2 profits, but grows revenue

Medical device contract manufacturing giant Integer Holdings Co. (NYSE: ITGR) reported a mixed bag when it came to second-quarter results. Nearly two years after Greatbatch and Lake Region Medical merged to create Frisco, Texas–based Integer, sales are growing, but second-quarter profits did not meet analysts’ expectations, according to earnings released yesterday evening. Integer earned $3.0

Integer interim CEO gets ‘interim’ removed from title

Medical device contract manufacturing giant Integer Holdings Co. said today that interim CEO Joseph Dziedzic will take over the company for good. Dziedzic is a former Integer board member who took over in March after Thomas Hook stepped down from the top spot. He’s entered into a new three-year employment agreement with the Frisco, Texas–based

Medtech stocks: the best and worst of Q1 2017

More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the